| Slide | |
| Credits | 1 |
| History | 2 |
| PMH, PSH, Allergies, Meds | 3 |
| SH, FH, ROS | 4 |
| Physical Exam | 5 |
| 6 | |
| Admit Labs | 7 |
| Hospital Course | 8 |
| Admit CXR-PA | 9 |
| Admit CXR-Lat | 10 |
| Admit CXR-Close-up | 11 |
| CXR-5 yrs ago | 12 |
| Path Slides | 13 |
| 14 | |
| 15 | |
| 16 | |
| 17 | |
| 18 | |
| Admit CXR | 19 |
| Chest Thorax | 20 |
| Solitary Pulmonary Nodule (SPN) | 21 |
| Diagnosis | 22 |
| 23 | |
| 24 | |
| Diagnostic Labs | 25 |
| PFT's | 26 |
| Radiographic Eval | 27 |
| 28 | |
| Indications for Chest CT | 29 |
| CT | 30 |
| FDG Position Emission Tomography | 31 |
| CT-FDG PET Scan | 32 |
| CXR prior to PET | 33 |
| CT prior to PET | 34 |
| CT-FDG PET Scan | 35 |
| FDG PET | 36 |
| 37 | |
| 38 | |
| Therapeutic Decisions | 39 |
| Bayesian Analysis 80's | 40 |
| 41 | |
| 42 | |
| Probability of Malignancy of SPN 90's | 43 |
| Therapeutic Decisions | 44 |
| Biopsy of SPN | 45 |
| Surgery | 46 |
| Back to Patient | 47 |
| Hospital Course | 48 |
| 49 | |
| Probability of Malignancy | 50 |
| Decision Made | 51 |
| Coccidioidomycosis | 52 |
| 53 | |
| 54 | |
| 55 | |
| Clin Findings | 56 |
| 57 | |
| Dx of Coccidioidomycosis | 58 |
| 59 | |
| 60 | |
| 61 | |
| Extrapulmonary Dissemination | 62 |
| Risk Factors for Dissemination | 63 |
| 64 | |
| Uncomplicated Infections | 65 |
| Monitoring | 66 |
| Antifungal Therapy | 67 |
| Indicators for Severity | 68 |
| Antifungal Therapy | 69 |
| Chronic Pulm Coccidioidomycosis | 70 |
| 71 | |
| Nodules & Cavities | 72 |
| Management of Coccidioidomycosis | 73 |
| 74 | |
| Back to our Patient | 75 |
| Post-op Course | 76 |
| References | 77 |
| Thank you | 78 |